FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes novel modifications B and C of compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carbox-amide of the formula (I) 
and pharmaceutical composition showing anticonvulsant activity and comprising said crystalline modifications. Modifications exhibit higher rate of dissolving in water and gastric juice that is important in their using in therapeutic aims, for example, in acute attack of epilepsy. EFFECT: valuable medicinal properties of modifications. 14 cl, 1 tbl, 2 dwg, 3 ex
